Peru

Peru country outline

Estimated Number of Current PrEP Users

N/A

Aggregate Target Number of PrEP Users from All Projects (Planned and Ongoing)

2,500-3,000

Types of Delivery Projects

  • Demonstration projects
  • Implementation project

*Definitions of types of projects available in the glossary below.

Drug Registration Status

  • Gilead’s Truvada (TDF/FTC) is registered and approved for prevention
  • Generic versions of TDF/FTC are not approved for prevention

Research, Demonstration and Implementation Projects

Click here for a full list of ongoing and planned research/demonstration projects in Peru.

Policy Framework

Not available.

Funding

NIMH, NIH, UNITAID


Eligibility Criteria
Resources for Peru
Glossary of Terms

Last updated April 16, 2018.

News Spotlight